Evaluation of EphB4 as Target for Image-Guided Surgery of Breast Cancer

Cansu de Muijnck1, Yoren van Gorkom1, Maurice van Duijvenvoorde1

  • 1Department of Surgery, Leiden University Medical Center, 2300 RC Leiden, The Netherlands.

Abstract

Insights

Tyrosine kinase receptor EphB4 shows enhanced expression in breast cancer cells, making it a promising target for image-guided surgery. This finding is particularly relevant for Her2-negative breast cancer cases.

Area of Science:

  • Oncology
  • Surgical Oncology
  • Molecular Biology

Background:

  • Targeted image-guided surgery relies on tracers that bind preferentially to tumor cells.
  • Identifying specific tumor antigens is crucial for effective tracer localization in breast cancer.
  • Previous antigen targets for breast cancer image-guided surgery have yielded variable outcomes.

Purpose of the Study:

  • To evaluate tyrosine kinase receptor EphB4 as a potential target for image-guided surgery in breast cancer.
  • To determine if EphB4 expression is enhanced in breast cancer tissue compared to normal breast tissue.

Main Methods:

  • Immunohistochemistry was used to stain two independent tissue microarrays of matched tumor and normal breast tissue for EphB4.
  • Staining intensity and the percentage of stained cells were scored by two independent investigators.

Main Results:

  • Breast cancer cells demonstrated significantly enhanced membranous expression of EphB4 compared to adjacent normal breast tissue.
  • The elevated EphB4 expression in tumors was independent of patient age, tumor stage, or subtype, including Her2-status.

Conclusions:

  • EphB4 represents a promising molecular target for image-guided surgery in breast cancer.
  • The enhanced expression suggests potential utility, particularly in Her2-negative breast cancer patients.